Further to my previous post regarding Apabetalone and heart failure, the following is from an RVX news release from Jan 2, 2014.  I believe BKC helped me out once before when referencing this publication, I didn't want him to have to do it again :)

"In August 2013 a third publication in the Cell Journal, titled "BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure", used RVX-208 as one of the BET inhibitors that confirmed the potential for BET inhibitors as therapeutic targets in heart failure. The authors of this publication were primarily from various divisions of Harvard Medical School."